Last quarter (Q4 2022), Race Oncology Ltd.'s total revenue was AU$―, a decrease of ― from previous quarter. In Q4, Race Oncology Ltd.'s net income was AU$―. See Race Oncology Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 22	Jun 21	Jun 20	Jun 19
Total Revenue	-	-	-	-	-
Cost of Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
Operating Expense	-	AU$ 11.96M	AU$ 6.78M	AU$ 4.11M	AU$ 3.91M
Operating Income	-	AU$ -11.96M	AU$ -6.78M	AU$ -4.11M	AU$ -3.91M
Net Non Operating Interest Income Expense	-	AU$ 53.91K	AU$ 18.85K	AU$ 9.32K	AU$ 17.36K
Other Income Expense	-	AU$ 707.81K	AU$ 424.88K	AU$ 256.44K	AU$ 228.50K
Pretax Income	-	AU$ -11.20M	AU$ -6.34M	AU$ -3.85M	AU$ -3.66M
Tax Provision	-	AU$ 0.00	AU$ 0.00	AU$ 0.00	AU$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-
Net Income Common Stockholders	-	AU$ -11.20M	AU$ -6.34M	AU$ -3.85M	AU$ -3.66M
Basic EPS	-	AU$ -0.07	AU$ -0.05	AU$ -0.04	AU$ -0.05
Diluted EPS	-	AU$ -0.07	AU$ -0.05	AU$ -0.04	AU$ -0.05
Basic Average Shares	-	AU$ 153.31M	AU$ 130.96M	AU$ 106.59M	AU$ 79.84M
Diluted Average Shares	-	AU$ 153.31M	AU$ 130.96M	AU$ 106.59M	AU$ 79.84M
Dividend Per Share	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-
Total Expenses	-	-	-	-	-
Net Income From Continuing And Discontinued Operation	-	AU$ -11.20M	AU$ -6.34M	AU$ -3.85M	AU$ -3.66M
Normalized Income	-	AU$ -11.20M	AU$ -6.34M	AU$ -3.85M	AU$ -3.66M
Interest Expense	-	-	-	-	-
EBIT	-	AU$ -11.96M	AU$ -6.78M	AU$ -4.11M	AU$ -3.91M
EBITDA	-	AU$ -11.68M	AU$ -6.50M	AU$ -3.83M	AU$ -3.62M

Currency in AUD

Race Oncology Ltd. Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing